Ruth Exner Selected Research

Adenocarcinoma

1/2019

Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ruth Exner Research Topics

Disease

18	Breast Neoplasms (Breast Cancer) 11/2023 - 01/2009
7	Neoplasms (Cancer) 01/2022 - 03/2002
3	Pathologic Complete Response 12/2021 - 07/2017
3	Brain Neoplasms (Brain Tumor) 11/2021 - 01/2019
3	Sepsis (Septicemia) 12/2003 - 01/2002
2	Osteoporosis 01/2019 - 08/2015
1	Triple Negative Breast Neoplasms 01/2023
1	Congenital Abnormalities (Deformity) 01/2023
1	Contracture 01/2023
1	Prosthesis Failure 01/2023
1	Residual Neoplasm 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2019
1	Osteoarthritis 01/2019
1	Pneumonia (Pneumonitis) 01/2019
1	Adenocarcinoma 01/2019
1	Cataract (Cataracts) 01/2019
1	Hernia (Hernias) 01/2017
1	Margins of Excision 01/2017
1	Diverticulitis 01/2017
1	Noninfiltrating Intraductal Carcinoma (DCIS) 01/2017
1	Rectal Neoplasms (Rectal Cancer) 09/2015
1	Arthralgia (Joint Pain) 08/2015
1	Metabolic Bone Diseases (Osteopenia) 08/2015
1	Stroke (Strokes) 01/2009
1	Pulmonary Embolism 01/2009
1	Endometrial Neoplasms (Endometrial Cancer) 01/2009
1	Shock 12/2003
1	Septic Shock (Toxic Shock Syndrome) 12/2003
1	Endotoxemia 12/2003
1	Hypotension (Low Blood Pressure) 12/2003
1	Infections 01/2003
1	Myocardial Reperfusion Injury 03/2002
1	Respiratory Insufficiency (Respiratory Failure) 03/2002
1	Liver Diseases (Liver Disease) 03/2002
1	Infarction (Infarctions) 03/2002
1	Wounds and Injuries (Trauma) 01/2002

Drug/Important Bio-Agent (IBA)

6	Hormones (Hormone)IBA 01/2019 - 12/2003
3	Epirubicin (Ellence)FDA LinkGeneric 11/2023 - 12/2015
3	Docetaxel (Taxotere)FDA Link 11/2023 - 12/2015
3	Aromatase InhibitorsIBA 01/2019 - 11/2009
3	Diphosphonates (Bisphosphonates)IBA 12/2018 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 07/2017 - 09/2015
2	Phenobarbital (Luminal)FDA Link 11/2021 - 12/2015
2	Trastuzumab (Herceptin)FDA Link 01/2021 - 07/2017
2	L-BLP25IBA 01/2021 - 01/2020
2	Denosumab FDA Link 01/2019 - 08/2015
2	Estrogens (Estrogen)FDA Link 01/2016 - 11/2009
2	Glutamine (L-Glutamine)FDA Link 01/2003 - 01/2002
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2023
1	pembrolizumabIBA 01/2023
1	Androgen Receptors (Androgen Receptor)IBA 11/2021
1	human ERBB2 proteinIBA 01/2021
1	Taxoids (Taxanes)IBA 01/2021
1	AnthracyclinesIBA 01/2021
1	pertuzumabIBA 01/2021
1	Cancer VaccinesIBA 01/2020
1	Estrogen ReceptorsIBA 01/2019
1	HMGB1 Protein (HMG1)IBA 01/2016
1	RANK LigandIBA 08/2015
1	Tamoxifen FDA LinkGeneric 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	CatecholaminesIBA 12/2003
1	Interleukin-6 (Interleukin 6)IBA 12/2003
1	CytokinesIBA 12/2003
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 12/2003
1	LipopolysaccharidesIBA 12/2003
1	InterleukinsIBA 12/2003
1	Epinephrine (Adrenaline)FDA LinkGeneric 12/2003
1	Glutathione (Reduced Glutathione)IBA 03/2002
1	Proteins (Proteins, Gene)FDA Link 03/2002

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2009
5	Neoadjuvant Therapy 11/2023 - 12/2015
5	Drug Therapy (Chemotherapy) 01/2023 - 11/2009
3	Radiotherapy 12/2021 - 01/2017
2	Mammaplasty (Breast Reconstruction) 01/2023 - 01/2017
1	Immunotherapy 11/2023
1	Precision Medicine 01/2022
1	Surgical Instruments (Clip) 01/2017
1	Colectomy 01/2017
1	Combination Drug Therapy (Combination Chemotherapy) 01/2016
1	Duration of Therapy 01/2009
1	Resuscitation 12/2003